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INTRODUCTION 
 The development of the concept of intraoperative evaluation of tissue 
diagnosis had revolutionary effect in the field of surgical oncology. 
 Intraoperative tissue diagnosis helps cancer surgeon 
1. To confirm pathological diagnosis when pre-operative diagnosis 
is inconclusive. 
2. To decide about the extent of the surgery 
a.  To avoid nodal dissection when sentinel node of nodal 
basin is negative and to complete nodal dissection when 
sentinel node is positive 
b. To assess the marginal status after excision and help to 
achieve margin free excisions 
3. To avoid the major ablative surgeries when, tumor has                     
metastasized beyond a proposed resection. 
4. To decide the definitive procedure after needle localization 
biopsy in suspected Ca. Breast. 
Currently intra operative evaluation is performed using 
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1.   Frozen section 
2.   Imprint cytology 
3.   Immuno Histo Chemistry 
4.   Molecular study  -    R.T PCR 
Touch imprint cytology is simple, quick and inexpensive and can be 
done even in centers where only basic pathology facility is available. Secondly 
the low cost and rapidity of this procedure is a big boon to the community 
based hospitals. 
Imprint cytodiagnosis is a relatively new technique that was introduced 
by Dudgeon & Patrick from UK and subsequently tried by several others in the 
last decade. The technique is relatively simple, cheap, reliable and does not 
require elaborate apparatus. The time required for imprinting a slide, staining 
and obtaining a readable result is only 6-8 minutes. Thus it is suggested, that in 
places where frozen section facilities are not available, imprint cytodiagnosis 
would be a valuable alternative. 
The mean accuracy rate for imprint cytology is 91% with range from 
78% to 98% in various literatures. 
The present study is mainly designed to determine the reliability of this 
procedure and to compare our results with literature. 
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AIM 
Touch imprint cytology is a simple and inexpensive method of detecting 
nodal metastatic disease even in centers, which do not have frozen section in 
their diagnostic armamentarium. Imprint cytology is reported to have a greater 
accuracy than frozen section since the latter is associated with higher false 
negative rate (25%). 
The aim of the present study is to evaluate our institutional experience 
with touch imprint cytology and to ascertain the reliability of touch imprint 
cytology as an intraoperative diagnostic tool in determining the histologic 
status of suspicious lymph nodes for metastasis and there by determining its 
sensitivity, accuracy, predictive value and its feasibility in our institution to aid 
the surgical oncologic procedures. 
However the present study is designed to assess the value of touch 
imprint cytodiagnosis in solid tumors by extrapolating its rich sentinel node 
experience from the many well-known studies. 
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REVIEW OF LITERATURE 
 Modern technique of intraoperative tissue diagnosis is one of the useful 
additions to the armamentarium of the cancer surgeon. 
 It helps to assess the extent of disease, whether or not tumor has 
metastasized beyond a proposed resection. 
NODAL MESTASTASIS 
 In solid tumors, clinical nodal staging is a major challenge. Clinical 
examination is influenced by the skill of the examiner, the patient’s body 
habitus and status of previous treatment like surgery, radiation and 
chemotherapy. As a result of these factors, the false negative rate in clinical 
assessment ranges from 20-30%. Imaging techniques such as CT scanning, 
MRI, US has been used for evaluation. The sensitivity of CT scanning is 81%. 
Size of the nodes and central lucency of nodes have been used as criteria for 
identifying positive nodes but there is a low specificity. Routine scanning of 
lymphatic basin is not justifiable at present. U.S. and with U.S. guided Fine 
Needle Aspiration, the accuracy has improved to 89% but it is highly operator 
dependent. No pre-treatment study can accurately assess or replace the 
histopathology. Hence the goal of identifying the sub clinical disease without 
surgical intervention remains elusive. 
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It is well known that 20% to 40% of patients with solid tumor who have 
no palpable disease in their lymphatic basin will harbor occult disease. It is 
therefore, therapeutically tempting to treat these patients on the basis that this 
will avoid subsequent treatment, which may not be as effective. It means that 
60%-80% of patients are "over-treated" and exposed to unnecessary morbidity 
and even mortality.   
OPTIONS OF THE MANAGEMENT OF THE N0 NODE 
1. Wait and watch 
2. Prophylactic nodal dissection 
3. Intraoperative lymphatic mapping and   sentinel node biopsy. 
4. Selective lymphadenectomy and intra operative tissue diagnosis 
Wait and watch policy is not justifiable 
It is well known that only 20% to 40% of patients with solid tumor, who 
do not have clinically apparent node, will harbor occult disease. Prophylactic 
Nodal dissection in these patients will result in 60% to 80% of patient getting 
over-treatment with significant morbidity. 
Intraoperative lymphatic mapping (ILM) and selective lymph node 
dissection (SLND) are revolutionary concepts that, in a short period, have 
shown the potential to alter dramatically the management of many patients with 
solid neoplasms. The rapid adoption of this approach to staging of solid 
neoplasms by the surgical oncology community has resulted in an explosion of 
data on this subject. 
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Despite lack of standardization of this technique, debate regarding the 
operative definition of a sentinel node and even the appropriateness of this 
approach outside of research settings, this approach continues. All reports from 
a variety of clinical settings, to date, however, support the original sentinel 
node hypothesis. Important issues remain unresolved, including standardization 
issues and the biologic relevance of immunohistochemical findings. It is 
apparent, however, that ILM provides greater diagnostic accuracy and lower 
morbidity, as substantial numbers of truly node-negative patients with 
cutaneous melanoma and breast cancer can be spared the morbidity of a 
regional node dissection that has no potential therapeutic value. 
In community hospitals like our institution where facilities for intra 
operative lymphatic mapping and sentinel node biopsy are not available, the 
alternative approach is selective lymphadenectomy and submission of the 
specimen for intraoperative pathological examination followed by radical nodal 
dissection if nodes were positive.  
CLINICAL APPLICATIONS 
HEAD AND NECK CANCER 
Comprehensive neck dissection is the standard treatment for obvious 
nodal disease in the neck. With emphasis on function preservation and 
cosmesis in addition to achieving adequate local disease control, conservative 
neck dissections have gained popularity. Growing historical evidence suggests 
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that modified and selective neck dissections offer disease control comparable to 
radical neck dissection but with less morbidity. 
A standard RND has no role in the management of patients with N0 
neck status. A SND, or rarely a MRND, would be required. A recent study has 
shown comparable recurrence rates for RND compared with SND with there 
being no statistically significant difference. It has to be emphasized that an 
END procedure must be "individualized". The decision regarding the type of 
neck dissection depends on the site of primary tumor, other tumor factors (e.g. 
location, depth, size, differentiation, vascular or perineural invasion), the 
patient and the surgeon undertaking the procedure. Tumors of the tongue, floor 
of mouth, nasopharynx, oropharynx, hypopharynx and supraglottic larynx have 
a high incidence of nodal metastases. In contrast, tumors of the buccal mucosa, 
lip, paranasal sinuses and glottic larynx metastasize less frequently. For a 
patient who stays some distance from the surgical centre and who is not 
expected to come for regular follow-up (and for unreliable patients) an MRND 
would be a better option. 
Asthana et al evaluated a novel method of intraoperative staging using 
sentinel node biopsy and intraoperative imprint cytology in 32 patients with 
head and neck cancer. Intraoperative imprint cytology (IIC) could accurately 
predict the false - negative result. The overall sensitivity, specificity, and 
accuracy of IIC were 87.5% 95.4% and 93.3% respectively. 
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BREAST CANCER 
 In the absence of metastatic disease, the single most predictor of 
outcome for women with breast carcinoma is the status of the regional lymph 
nodes. Traditionally, in patients with carcinoma of breast, axillary lymph node 
status has been evaluated by routine axillary lymph node dissection (ALND) 
with lumpectomy or mastectomy. ALND is used to obtain precise staging data, 
provide local control and for selection of adjuvant therapy. Unfortunately, the 
only patients who are likely to derive therapeutic benefit from ALND are 
patients with positive nodes. ALND is associated with considerable morbidity 
including lymphedema, neurological abnormalities principally to the 
intercosto-brachial nerves, shoulder stiffness and rarely angiosarcoma. The 
sentinel lymph node biopsy is an accurate predictor of the overall axillary nodal 
status and has both high sensitivity and specificity, especially T1, T2 tumors 
with no palpable axillary node. 
 The key advantage of intraoperative analysis of lymph nodes is the 
ability to stage patients during the initial operation while the patient is 
undergoing the surgical resection of the primary tumor. Intraoperative analysis 
of lymph nodes is clearly desirable as the surgeon may proceed with axillary 
dissection during a single procedure if the nodes are positive. The alternative 
would be to terminate the procedure after the sentinel lymph node biopsy is 
performed with the intention of returning to the operating room for a second 
procedure if the permanent histological evaluation confirms the presence of 
metastatic carcinoma. The second operative procedure likely results in higher 
costs and clearly results in increased patient anxiety and discomfort. High 
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levels of diagnostic accuracy are required for this one-stage procedure, as a 
false positive intraoperative diagnosis would lead to potentially unnecessary 
block dissection with its attendant morbidity. 
 Traditionally, frozen section evaluation has been the technique of choice 
for intraoperative tissue evaluation. Numerous studies of frozen section have 
been reported evaluating the utility of this technique for the intraoperative 
analysis of sentinel lymph nodes with rare false positives reported. Sensitivity 
has been quite variable ranging from less than 60% and up to 95% and number 
of factors contributes to this variability, including the size of the primary 
lesion, size and focality of metastasis, type of primary carcinoma and the 
number of frozen sections evaluated. 
CARCINOMA PENIS 
 The presence and extent of inguinal lymph node metastasis are the most 
important prognostic factors. In the absence of inguinal nodal metastasis, pelvic 
nodal metastasis is rare. Inguinal metastasis is potentially curable by         
lymphadenectomy alone. Pelvic nodal metastasis is often incurable. 20% of 
clinically negative nodes harbor occult lymphatic metastasis. 
 Standard management of nodal disease is Ilio-Inguinal Block Dissection. 
It is associated with considerable chronic morbidity including skin necrosis, 
lymphedema, wound infection, seroma and femoral hernia. 
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GASTROINTESTINAL MALIGNANCY 
 Extent of Lymphadenectomy in gastric Cancer is debatable.  
            D2 Lymphadenectomy has no survival benefit in western series. In 
contrast, Japanese results have definitive survival benefit. N3 Nodes - Para 
Aortic, mesenteric and Retro Pancreatic Nodes are considered as metastatic 
disease. Involvement of these Nodes is incurable. 
In Colon Cancer, involvement of principal Nodes- S.M.A, I.M.A. Nodes 
are incurable. 
Prem Sharma et al., correlating with definite histology work up, studied 
imprint Cytology in the diagnosis of gastrointestinal tract malignancies. They 
found that overall diagnostic accuracy of histology and Imprint Cytology in 
esophagus, stomach and lower gastrointestinal tract was 95%, 98%, 98% and 
95%, 100%, 98% respectively. When combined, the diagnostic accuracy 
increased to 98%, 100% and 100% in esophagus, stomach and lower 
gastrointestinal tract respectively. 
GYNECOLOGICAL CANCER 
 In Ca. Cervix, pelvic nodal metastasis is associated with poor prognosis. 
It warrants adjuvant radiotherapy. Involvement of para aortic node is incurable. 
Radical surgeries like Wertheim’s hysterectomy and pelvic exenteration are 
contra indicated when Para aortic nodes are involved. 
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     Bhabra et al, from U.K described the value of the technique applied to 
intraoperative diagnosis of lymph node metastases in Gynecological 
malignancy. 475 Lymph nodes were examined using Intraoperative tissue 
diagnosis followed by routine histology. The technique of Intraoperative tissue 
diagnosis was found to have zero false negative rates, 0.6% false positive rate 
and accuracy of 99.3%.  
THYROID CANCER 
 In solitary thyroid nodule, to differentiate between benign and malignant 
swellings, FNAC is helpful. The sensitivity is 90%. But accuracy of imprint 
cytology is greater than FNAC. Imprint cytology is not useful to differentiate 
between follicular adenoma and Carcinoma, where histology is a must to 
examine capsular and vascular invasion  
NEEDLE LOCALISED BREAST BIOPSIES 
 Shabaik et al., studied the relevance of Imprint Cytology in 503 needle 
localized breast biopsies and they concluded that intraoperative evaluation of 
needle localized breast biopsy can provide the surgeon with information useful 
to immediate clinical management and also indicated that while Imprint 
cytology and Frozen Section are occasionally complementary, increased 
reliability in Intraoperative cytological diagnosis will allow the surgical 
pathologists to conduct diagnostic and prognostic studies on artifact free and 
intact lesional tissues. 
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IMPRINT CYTOLOGY IN SURGICAL MARGINS 
 Andrew J.Creager et al. extended the Imprint Cytology technique for 
evaluating surgical margins intraoperatively to achieve margin free excisions to 
be performed during the initial surgery. He concluded that Imprint Cytology 
evaluation in breast conservation therapy is a simple, rapid, accurate and cost 
effective method for intraoperative determination of margin status that can be 
reproduced in the community hospital setting. It allows for evaluation of the 
entire surface area of the lumpectomy specimen, whereas such evaluation is 
impractical using Frozen Section because of time restrictions and the technical 
challenges associated within cutting frozen sections of adipose tissue, 
especially if extensive calcifications are present. Finally, Imprint Cytology may 
reduce local recurrence rates and improve cosmesis in patients undergoing 
breast conservation treatment. 
OPTIONS–INTRA OPERATIVE TISSUE EVALUATION 
 
1. Frozen section 
2.  Imprint cytology 
3.  ImmunoHistoChemistry. 
4. Molecular study – RT PCR 
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FROZEN SECTION 
ADVANTAGES OF FROZEN SECTION ANALYSIS 
 Maintenance of normal lymph node architecture and familiarity of 
pathologists with the technique with preserved architecture, pathologists may 
pay added attention to regions such as the subcapsular sinuses an area with a 
known predilection for harbouring metastasis. 
DISADVANTAGES OF FROZEN SECTION ANALYSIS 
 Unfortunately Frozen section analysis has several disadvantages. 
Sectioning the node in the cryostat may consume large amounts of tissue that 
are unfortunately lost for future evaluation. In addition, freezing artifact may be 
produced both in the Frozen section itself and in subsequent permanent 
sections from the same block. Thus, the probability of missing micrometastases 
is increased due to tissue loss and there is interpretation difficulty secondary to 
freezing artifact. 
 The size of the lymph node is a factor that can affect intraoperative 
evaluation of the nodal metastasis. This problem usually affects frozen section 
evaluation because it can be difficult to cut the large pieces of lymph node onto 
a glass slide especially when partially or wholly replaced by fat. There are no 
such limitations with Intraoperative Imprint Cytology 
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 Although, intra operative examination of the sentinel lymph node may 
avoid the cost and operative morbidity of a separate surgical operation when 
the node shows tumor cells, previous sentinel lymph node studies with frozen 
section have reported variable results.  
 Frozen section histological examination of lymph nodes is known to 
have a high false negative rate of upto 27%. Imprint cytology has been reported 
to have a lower false rate with the sensitivity reaching 100% is some studies. 
IMPRINT CYTOLOGY 
 Imprint cytology is for many reasons, a much more practical method 
with which to evaluate lymph nodes intraoperatively and it appears to be a 
viable alternative to frozen sectioning. Cost and rapidity of intra operative 
analysis are other factors that must be considered.  At our institution, 
intraoperative touch preparation analysis can be performed quickly and at a 
substantially lower cost than traditional frozen section histology. The cost of 
frozen section is significantly greater than intraoperative Imprint Cytology. 
 One study, however, noted a false positive result (1%) on intraoperative 
Imprint cytology a potential problem that also has been observed using Imprint 
cytology of low axillary lymph nodes sample.  Although a rare false positive 
result could occur with frozen section examination, it has not yet been 
described and seems to be a potentially greater problem with Imprint cytology 
techniques. 
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 To minimize the possibility of false - positive results, intraoperative 
indeterminate results (atypical/suspicious) results, which occurred during study 
are regarded as negative at the time of surgery and at final diagnosis, unless 
confirmed positive on H & E. In indeterminate results, the reactive histocytes, 
lymphocytes, and endothelial cells may appear atypical and occasionally 
difficult to distinguish from a micrometastasis. This is a greater problem with 
Imprint cytology-. 
The possible reasons for the false positive result are. 
1. First the Imprint cytology specimen contained the only metastatic 
deposit in the part of the lymph node that was lost in the deeper sections 
of the lymph node and consequently not found on final histopathology. 
2. Second the specimen could be contaminated as reported also in few 
studies. 
ACCURACY OF INTRAOPERATIVE RESULTS 
 The accuracy for Imprint cytology ranges from 78 to 98% with a mean 
of 91%. The mean accuracy for frozen section in literature is 89% with a range 
from 83 to 96%. 
INTRAOPERATIVE TIME FOR TOUCH IMPRINT CYTOLOGY 
 A median waiting time of 25 min. for the results in the present study is 
acceptable and allows the surgeon to perform definitive surgery on the primary 
tumor while awaiting results of the Imprint cytology. 
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FACTORS MODIFYING THE OUTCOME OF THE RESULTS 
 Direct comparisons between series published by different institutions are 
problematic due to difference in processing methodologies, patient populations, 
and outcome measures. Many factors can affect intraoperative touch 
preparation accuracies including reagents, the number of lymph nodes 
evaluated, the number of node sections made and the time constraints placed 
upon the pathology team. Among these are the proportions of patients who 
have lymph node positive disease versus early stage disease, the prevalence of 
solely micrometastatic disease, and the prevalence of invasive lobular patients, 
whose histology is generally accepted to be more difficult to evaluate 
intraoperatively. 
REPORTING SYSTEM 
Reporting of the imprint cytology should be quick and accurate. False 
positivity leads to unnecessary mutilating and irreversible surgical procedure 
and false negativity leads to unnecessary delay for second operation. 
Report should be as little as possible and as much as needed. Heroic 
demonstration of pathologist skill is not required. 
The lab should be in the same building where operation theatre is 
located. 
Imprint cytology processing is an emergency to pathologist who is 
normally not familiar with daily stress of surgeon. 
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Touch Imprint cytology Versus Frozen section 
 Touch Imprint Cytology Frozen Section 
1. Rapid (< 10min) Time consuming (30 min) 
2. Inexpensive More expensive 
3. Preserve tissues 50% tissue lost 
4. Highly specific Less specific 
5. No artifacts Freeze thaw artifacts 
6. Easy to perform multiple slides Serial sectioning very time 
consuming 
  
          The advantages of Touch Imprint cytology over frozen section are 
numerous. 
 It is quicker; taking about 5-10 min, as compared with more than 20 to 
30 min. for frozen section analysis. 
 Therefore touch preparation can decrease both anaesthetic time and 
operative time considerably. In addition, Touch Imprint cytology does not have 
the disadvantage of tissue destruction and freeze thaw artifact that occurs 
routinely with the frozen section technique. 
                   LYMPH NODE MICROMETASTASIS 
 Lymph node metastases were defined as those meaning greater than 
2mm in size as macrometastases and those falling short of 2mm size were 
labelled as micrometastases and compared against the currently accepted 
standard of H & E histology. 
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 Unfortunately, the related subject of lymph node micro metastasis 
sometimes clouds the clarity with which the literature speaks on the subject of 
the significance of occult lymph node metastases in breast cancer, which is 
somewhat more obscure. Regrettably, many studies use the terms Occult 
metastases and micrometastases interchangeably, despite the fact that occult 
metastases often are quite large, replacing considerable Portions of the node 
with malignant deposits. 
 Micrometastases, as the name implies, are microscopic deposits of 
tumor in lympth nodes. There is, however, no consensus on the definition of a 
micrometastasis, with various publications using upper limits of 0.2 to 2.0 mm 
and others using definitions based on the area of tumor involvement, such as 
<20% of the lymph node cross sectional area. 
 Macrometastases were identified successfully by Imprint cytology and 
frozen section in 98% of patients. ≤ 2.0mm detected by Imprint cytology and 
frozen section in only 28% of cases. When lymph node metastasis is seen, 
several factors influence the sensitivity of both imprint and frozen section 
evaluation of sentinel lymph node. The first critical factor is the size of 
metastasis. In breast carcinoma, the sensitivity of detecting micrometastasis is 
low because of the focal nature and small size of the metastases. Infact, in an 
exhaustive Frozen section study of sentinel lymph node in patients with breast 
carcinoma, Viale et al., sectioned lymph nodes completely intraoperatively, 
using both H & E staining and intraoperative cytokeratin immuno staining at 
each level. In that study, the detection of macrometastasis usually occurred 
after examination of the first Frozen section level. Detection of 
 28
micrometastates was more problematic because they tended to be scattered 
unpredictably throughout the lymph node 
MICROMETASTASES AND ITS CLINICAL IMPLICATION 
 The disadvantage of potentially missing some micrometastasis due to 
loss of tissue is clearly outweighed by the advantage of performing an axillary 
lymphadenectomy in the first operation in a sentinel node positive patient. 
 Shiver et al., also found that Imprint cytology was significantly more 
sensitive for macrometastasis (87%) than for micrometastasis (22%). 
 In the study by Lee et al., 83% of false negative Imprint cytology cases 
were due to micro metastasis. 
 Llatjos et al., using imprint cytology and rapid cytokeratin 
immunostaining reported that 80% of their false-negative results were due to 
micrometastasis. Only one micrometastasis was detected by intraoperative 
Imprint cytology. 
 Recently Creager et al. reported that sensitivity for macrometastases was 
significantly better than for micrometastases (81 and 21% respectively) in a 
series of 646 patients. Identification of micrometastases is problem not only in 
Imprint cytology but also in frozen section. This may not be a serious limitation 
of intraoperative Imprint Cytology, because patients with sentinel node 
macrometastases can reliably be detected by imprint cytology and are most 
likely to benefit from complete lymphadenectomy. 
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 The benefit of the completion axillary lymphadenectomy in patients 
with micrometastatic disease in the sentinel node is unknown and questionable 
because of the controversial role of regional control on survival and the 
beneficial effect of adjuvant systematic therapy. In the future, the results of 
international prospective clinical trials will probably show that a completion 
axillary lymph node dissection will not be necessary for micrometastatic 
sentinel node disease. 
 Although touch preparations have a false negative rate of 4.9% this is 
likely not to be clinically significant, as it represents micrometastatic disease, 
which carries a low likelihood of additional nodal pathology. Therefore in this 
subset of patients, a "MISS" on touch imprint evaluation does not usually 
translate into a return to the operative suite 
REVIEW OF INTRA OPERATIVE TOUCH IMPRINT CYTOLOGY 
RESULTS 
 The need for the intraoperative assessment of nodal metastasis seems 
justified, as it may obviate the need for a second operation and this is bolstered 
by findings from Motomora et al., reported the results of Imprint cytological 
examination of sentinel lymph nodes with 90.9%. Sensitivity, 98.5% specificity 
and 96% overall accuracy and for Frozen section were 52% sensitivity, 100% 
specificity, 88% accuracy. He concluded that Imprint cytology could detect 
micrometastasis more accurately than the conventional H & E staining 
sectioning. Scerni et al. demonstrated the imprint analysis had a sensitivity of 
83% and a negative predictive value of 86%. False positive cases rarely occur 
with trained cytopathologists, and only one such a case was reported by Ku  
et al. 
 30
Karamlou et al., had shown that appraisal of the sentinel lymph node 
analysing touch imprint cytology will accurately predict a positive axillary 
node with a positive predictive value of 100% and a negative predictive value 
of 95% and so, would recommend that all patients with a positive touch 
preparation result have complete axillary dissection, as they had no false 
positives in our experience Although the Touch Imprint Cytology technique 
had a false negative rate of 4.9%, he believed that it still leads to clinically 
appropriate management of the axilla. The false negative results all occurred in 
the setting of micrometastases. 
 Veronesi et al., reported sensitivity and specificity of more than 90% for 
intraoperative frozen section analysis of sentinel nodes with the use of multiple 
sections involving most of nodal tissue and with intraoperative pathology time 
in excess of 40 minutes. Although this technique is possible, it is not feasible 
for many centers in terms of time and cost, and it can be performed only at the 
expense of loss of all nodal tissue for subsequent analysis. Other groups 
performing less complex frozen section analysis have been unable to duplicate 
these results although Van Diest et al., also achieved high accuracy with Frozen 
section with less tissue analysed and with shorter processing times, they 
thought this procedure to be preferable to Imprint cytology. 
 The largest series by Henry - Tillman et al., involved 479 sentinel lymph 
nodes and 247 patients. The authors reported a “per node sensitivity” of 94% 
and a positive predictive value of 98% on a “per patient” basis, sensitivity was 
91%5. Other authors also report similar sensitivities. However in many of these 
series, touch preparation technology was evaluated to determine the diagnostic 
accuracy of the test itself and not to influence on intraoperative decision for 
possible immediate axillary lymphadenectomy. 
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MATERIALS AND METHODS 
We examined 70 samples in 45 patients with various tumors in this 
study between July 03 and Sep. 2005. There was no age restriction and patient 
age ranged from 27 to 70 years.  
A Retrospective Analysis of 44 pts whose surgical procedures were 
based an imprint cytology, were analyzed. 
Oral cancers - 5 Cases - with clinically negative nodes with having high 
risk for nodal metastasis was treated by supraomohyoid Block dissection and 
then submitted for imprint cytology. R.N.D. was done for all patients with 
positive results.  
 Ca penis- 6 cases-and skin tumors in lower limb -2 cases - with 
palpable inguinal nodes after antibiotic treatment was treated by Superficial 
Inguinal block dissection followed by IIBD based on imprint cytology. 
8 cases of Post R.T cervical cancer with adjacent organ invasion were 
selected for pelvic exenteration provided if para aortic nodal - Imprint 
Cytology is negative. 
In 6 cases of Thyroid Solitary Nodules was treated by hemi 
thyroidectomy and imprint cytology followed by total thyroidectomy if it is 
positive. 
 33
In 3 cases of gastric cancer, Para aortic nodal sampling and imprint 
cytology was done to decide D2 gastrectomy only if it is negative. 
In 9 cases of Ca breast after Axillary dissection the nodes were 
submitted for imprint cytology to compare with HPE report. 
In 3 cases of Lymphoma after nodal Biopsy, the result of both imprint 
and HPE were compared. 
 Testicular cancer with retroperitoneal nodes (1 case) after salvage 
chemotherapy, it was submitted imprint cytology to compare with HPE report. 
After the surgical procedures were performed the specimen was 
submitted for evaluating the pathological status by touch imprint cytodiagnosis, 
followed by definite paraffin sections. The minimum size of the node as 
inclusive criteria into the study was prefixed as 1 cm. 
The clinical details and other relevant findings regarding the patient 
were informed priorly to the attending pathologist to hasten up the 
intraoperative pathologic processing period. 
As soon as suspicious lymph nodes were excised they were carefully 
labeled and delivered fresh to the room adjacent to the operating suite. 
Intraoperative Pathologic Evaluation  
The freshly received lymph node initially was measured and fibro fatty 
tissue surrounding the lymph node was removed accurately without disturbing 
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the lymph node capsule, before bisecting the lymph node along its long axis. 
Care was taken to obtain complete cross sections of the maximum dimension, 
preferably including the hilum and the marginal sinus. 
From the freshly cut, flat surface of specimen, imprints were taken by 
gently touching the flat surface firmly with a standard glass slide twice or 
thrice. Two slides were prepared from each specimen. 
The imprints from each surface were fixed immediately in alcohol for 
few minutes and then stained immediately with rapid H & E technique. 
Rapid hematoxylin and eosin stain - Standing Procedure 
1. Fix smear in 10 per cent neutral buffered formalin at room for 20 
seconds. 
2. Rinse in tap water 
3. Stain in Harris's (Progressive) hematoxylin for 1 minute. 
4. Wash well in tap water for 10 - 20 seconds. 
5. Stain in 1 per cent aqueous eosin for 10 seconds. 
6. Rinse in tap water. 
7. Dehydrate, clear and mount 
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Single experienced pathologist reported all the slides. The diagnosis was 
rendered in an average of 20 minutes and communicated to the Surgeon Via 
Telephone or in person. 
 
Diagnostic categories use in reporting cytological finding included. 
1. Negative for malignancy. 
2. Atypical cells seen, suspicious for malignancy. 
3. Positive for malignancy. 
Permanent Section slides were prepared as routine for all specimens and 
were reported by same pathologist.  
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LT. AXILLARY DISSECTION 
   RT. AXILLARY DISSECTION 
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PARA - AORTIC NODAL DISSECTION 
PELVIC NODAL DISSECTION 
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RT- COMPOSITE DISSECTION  
LT- COMPOSITE DISSECTION  
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D2 GASTRECTOMY SPECIMEN 
D2 GASTRECTOMY 
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HEMITHYROIDECTOMY - SPECIMEN 
RT- HEMITHYROIDECTOMY 
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COMPOSITE RESECTION SPECIMEN 
TOTAL THYROIDECTOMY - SPECIMEN 
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ILIO INGUINAL BLOCK DISSECTION 
 SUPERFICIAL  INGUINAL 
 BLOCK DISSECTION 
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TOTAL PELVIC EXENTERATION –SPECIMEN 
TOTAL PELVIC EXENTERATION –STOMAS 
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BISECTED NODE 
                NODE - BEFORE BISECTION 
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IMPRINT SMEAR - FROM SPECIMEN 
IMPRINT SMEAR - FROM NODE 
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IMPRINT SMEAR - PROCESSING  
IMPRINT SMEAR  
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IMPRINT SMEAR - PARA AORTIC NODE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IMPRINT SMEAR - INGUINAL NODE
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HISTOPATHOLOGY - PARA AORTIC NODE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HISTOPATHOLOGY - INGUINAL NODE 
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MASTER CHART 
 
Pt. 
No. 
Name Age/Sex 
Path. 
No. 
Primary Cancer No. Of Imprint Node/Specimen IC HPE 
1. Jayanthi 36F 853/03 Ca.thyroid 1 
.2 
L-Hemithyroidectomy 
L-Paratracheal node 
Negative 
Negative 
Negative 
Negative 
2. Petchiammal 45 F 1214/03 Ca. Thyroid 3. 
4. 
L-Hemithyroidectomy 
L-Paratracheal node 
Negative 
Negative 
Negative 
Negative 
3. Malliga 45F 1028/03 Ca.Cervix  5. 
6. 
Para aortic node (1) 
Para aortic node (2) 
Positive 
Positive 
Positive 
Positive 
4. Kannan 58M 1029/3 Ca.Tongue  7. R-Supraomahyoid node Positive Positive 
5. Chinnaian 40M 1039/03 (R) Leg - SCC 8.  R -Inguinal node Positive Positive 
6. Soundararajan 43 M 1059/03 Ca.Bladder 9 
10. 
Para aortic node (1) 
Para aortic node (2) 
Positive 
Sus. 
Negative 
Negative 
7. Raghu 65M 1199/03 Ca. Penis 11. 
12. 
R-Inguinal node (1) 
R-Inguinal node (2) 
Positive 
Positive 
Positive 
Positive 
8. Balaganga 44F 1219/03 Ca.Cervix 13. 
14. 
Para aortic node (1) 
Para aortic node (2) 
Negative 
Negative 
Positive 
Negative 
9. Alagami 44F 1301/03 Ca.Cervix 15. 
16. 
Para aortic node (1) 
Para aortic node (2) 
Positive 
Positive 
Positive 
Positive 
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Pt. 
No. 
Name Age/Sex 
Path. 
No. 
Primary Cancer No. Of Imprint Node/Specimen IC HPE 
10. Hemavathy 48F 1337/03 Ca. Breast 17. R-Axillary node Positive Positive 
11. Meenakshiammal 55F 1362/03 Ca.Stomach 18. Para aortic node Negative Negative 
12. Chadrasekhar 44M 254/04 Ca.Penis 19. 
20. 
21. 
R -Inguina node (1) 
R -Inguinal node (2) 
R - Inguinal node (3) 
Negative 
Negative 
Negative 
Positive 
Negative 
Positive 
13. Vijaya 40F 263/04 Ca. Breast 22. R-Axillary node Negative Negative 
14. Noorjahan 40F 281/04 Ca.Breast 23. R-Axillary node Positive Positive 
15. Chandrasekaran 46M 291/04 Ca.Penis 24. 
25. 
L-Inguinal node (1) 
L-Inguinal node (2) 
Negative 
Negative 
Positive 
Negative 
16. Dhanalakshmi 35 F 295/04 Ca. Cervix 26. 
27. 
Para aortic node (1) 
Para aortic node (2) 
Positive 
Positive 
Positive 
Positive 
17. Anthony 60 M 308/04 Ca. Penis 28. 
29. 
30. 
L-Inguinal node (1) 
L-Inguinal node (2) 
L-Inguinal node (3) 
Positive 
Negative 
Negative 
Positive 
Positive 
Negative. 
18. Anthony 50 M 421/04 Ca. Penis 31. 
32. 
L- Inguinal node (1) 
L-Inguinal node (2 
Negative 
Negative 
Positive 
Positive 
19. Kanniammal 66 F 526/04 Ca. Cervix 33. Para aortic node Negative Negative 
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Pt. 
No. 
Name Age/Sex 
Path. 
No. 
Primary Cancer No. Of Imprint Node/Specimen IC HPE 
34. Para aortic node Negative Negative 
20. Elumalai 58 M 575/04 Ca. Bladder 35. R-Ext. Iliac node Positive Positive 
21. Neelamma 40F 709/04 Ca. Breast 36. R-Axillary node Positive Positive 
22. Vimala 27F 683/04 Ca.Thyroid 37. L-Hemi Thyroidectomy  Positive Positive 
23. Badrunisha 46F 714/04 Ca.Breast 38. R-Axillary node Negative Negative 
24. Sameer 32 M 728/04 Ca. Tongue 39. 
40. 
R-Supraomohyoid node (1) 
R-Supraomohyoid node (2) 
Positive 
Positive 
Positive 
Positive 
25. Kamatchi 55 F 707/04 Ca. Tongue 41. R-Supraomohyoid node Positive Positive 
26. Papammal 38F 741/04 Ca.Cervix 42. 
43. 
Para aortic node - (1) 
Para aortic node - (2) 
Negative 
Negative 
Positive 
Positive 
27. Chandra 55F 778/04 Ca.Breast 44 L-Axillary node Negative Positive 
28. Poongothai 28 F 834/04 Ca.Thyroid 45. L-Hemithyroidectomy Negative Negative 
29. Gangeyan 65M 802/04 Ca. Cheek  46. L-Supraomohyoid node Negative Positive 
30. Ram 70 M 869/04 Ca. Penis 47. L-Inguinal node Negative Positive 
31. Lourdamary 55 F 880/04 Ca.Breast 48. 
49. 
50. 
R-Axillary node - (1) 
R-Axillary node - (2) 
R-Axillary node - (3) 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
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Pt. 
No. 
Name Age/Sex 
Path. 
No. 
Primary Cancer No. Of Imprint Node/Specimen IC HPE 
32. Raman 60 M 883/04 Ca. Stomach 51. 
52. 
Para aortic node (1) 
Para aortic node (2) 
Sus. 
Negative 
Negative 
Negative 
33. Selvammal 47 F 885/04 Ca.Breast 53. L-Axillary node Negative Negative 
34. Indiramma 55 F 900/04 Ca. Breast 54. 
55. 
56. 
L-Axillary node - (1) 
L-Axillary node - (2) 
L-Axillary node - (3) 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
35. Raman 70 M 901/04 Hodgkins 
Lymphoma 
57. L-Axillary node Sus. Positive 
36. Ganesan 17 M 940/04 Hodgkins 
Lymphoma 
58 L-Cervical node Sus. Positive 
37. Kannan 54 M 944/04 Ca.Tongue 59. 
60. 
L-Supraomohyoid node (2) 
L-Supraomohyoid node (3) 
Positive 
Positive 
Positive 
Positive 
38. Dhanalakshmi 35 F 958/04 Ca.Thyroid 61. 
62. 
R-Hemithyroidectomy  
R-Paratreacheal node 
Negative 
Negative 
Negative 
Negative 
39. Selvaraj 45 M 1425/04 Lymphoma 63. 
64. 
L-Inguinal node 
L-Inguinal node 
Negative 
Negative 
Negative 
Negative 
40. Manikkam 40/M 1109/05 Testicular Tumour 65. Lt. Pelvic Node Negative Negative 
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Pt. 
No. 
Name Age/Sex 
Path. 
No. 
Primary Cancer No. Of Imprint Node/Specimen IC HPE 
41. Ayyammal 55/F 1232/05 Melenona Rt. Foot 66. Rt. Inguinal  Node Negative Negative 
42. Viji 25/F 1242/05 Ca.Thyroid 67. Hemithyroidectomy Negative Negative 
43. Tarabai 40/F 683/05 Ca.Cervix 68. Para aortic node Negative Negative 
44. Ravanammal 45/F 1077/05 Ca.Cervix  69. Para aortic node Negative Negative 
45. Akbar Ali 45/M 1160/05 Ca. Stomach 70. Para aortic node Positive Positive 
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RESULTS AND  
OBSERVATIONS 
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RESULTS 
 
                      CASE DISTRIBUTION – DIAGNOSIS BASED 
 
Diagnosis No. Percentage 
Ca Breast. 9 20 
Ca. Cervix 8 17 
Ca. Penis 6 14 
Ca. Thyroid 6 14 
Oral Cancer 5 11 
Lymphoma 3 7 
Ca.Bladder 2 4 
Skin Tumor 2 4 
Ca. Stomach 3 7 
Testicular Tumor 1 2 
 44 100 
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                 CASE DISTRIBUTION – SPECIMEN BASED 
 
 
 
 
SPECIMEN NO. PERCENTAGE 
Para aortic nodes 12 25 
Inguinal nodes 9 20 
Axillary Nodes 9 20 
Cervical Nodes 7 16 
Hemi Thyroidectomy 6 14 
Pelvic Nodes 2 5 
 45 100 
 
 
CASE DISTRIBUTION  
 NO. OF NODE/SPECIMEN SLIDE BASED 
Region Count Percent 
 Axillae 14 20 
Cervical  9 13 
 Inguinal 17 24 
 Para-aortic  20 29 
 Pelvic  2 3 
Thyroid  8 11 
 70 100 
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CASE DISTRIBUTION - DIAGNOSIS BASED
3 1
2
2
3
5
6
6
8
9
Ca. Breast Ca. Cervix Ca. Penis Ca. Thyroid Oral Cancer Lymphoma Ca. Bladder Skin Tumor Ca. Stomach Testicular Tumor
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Thyroidectomy
Pelvic nodes
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CASE DISTRIBUTION - SPECIMEN BASED
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CASE DISTRIBUTION - NO.OF IMPRINT SLIDE BASED
14
9
17
20
2
8
Axillae Cervical Inguinal Para-aortic Pelvic Thyroid
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RESULTS 
 Out of 5 supra-omohyoid block dissections done for oral cancers, 4 were 
positive in imprint cytology and the dissection extended to M.R.N.D. 
 Out of 8 superficial inguinal block dissection (5 cases for Ca. Penis and 
3 cases for skin tumor) 3 were positive and were treated by I.I.B.D. 
 In 6 thyroid swellings, 5 were negative for malignancy and 1 was 
positive and was treated by total thyroidectomy. 
 8 post RT Ca Cervix cases were planned for pelvic exenteration. In 
imprint cytology 3 patients had para aortic nodal metastasis and the procedures 
were done only in the remaining 5 cases. 
 In 3 Gastric cancers, 2 cases underwent D2 gastrectomy after ruling out 
the para aortic nodal metastases. In 1 case it was positive and was treated by 
palliative gastric resection 
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OBSERVATIONS FROM THE STUDY 
Primary Site Lesion Specimen Node No. IC HPE 
Result 
Category. 
Thyroid Thyroid 1 n n TN 
Thyroid Thyroid 2 n n TN 
Thyroid Thyroid 3 n n TN 
Thyroid Thyroid 4 n n TN 
Cervix Para-aortic 5 p p TP 
Cervix Para-aortic 6 p p TP 
Leg Inguinal 8 p p TP 
Bladder Para-aortic 9 p n FP 
Bladder Para-aortic 10 n n TN 
Penis Inguinal 11 p p TP 
Penis Inguinal 12 p p TP 
Cervix Para-aortic 13 n p FN 
Cervix Para-aortic 14 n n TN 
Cervix Para-aortic 15 p p TP 
Cervix Para-aortic 16 p p TP 
Breast Axillae 17 p p TP 
Stomach Para Aortic 18 n n TN 
Penis Inguinal 19 n p FN 
Penis Inguinal 20 n p TN 
Penis Inguinal 21 n p FN 
Breast Axillae 22 n p TN 
Breast Axillae 23 p p TP 
Penis Inguinal 24 n p FN 
Penis Inguinal 25 n n TN 
Cervix Para Aortic 26 p p TP 
Cervix Para Aortic 27 p p TP 
Penis Inguinal 28 p p TP 
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Primary Site Lesion Specimen Node No. IC HPE 
Result 
Category. 
Penis Inguinal 29 n p FN 
Penis Inguinal 30 n n TN 
Penis Inguinal 32 n p FN 
Penis Inguinal 32 n p FN 
Cervix Para Aortic 33 n n TN 
Cervix Para Aortic 34 n n TN 
Bladder Pelvic 35 p p TP 
Breast Axillae 36 p p TP 
Thyroid Thyroid 37 p p TP 
Breast Axilla 38 n n TN 
Tongue Cervical 39 p p TP 
Tongue Cervical 40 p p TP 
Tongue Cervical 41 p p TP 
Cervix Para Aortic 42 p p TP 
Cervix Para Aortic 43 n p FN 
Breast Axillaa 44 n p FN 
Thyroid Thyroid 45 n n TN 
Cheek Cervical 46 n n TN 
Penis Inguinal 47 n p FN 
Breast Axillae 48 p p TP 
Breast Axillae 49 p p TP 
Breast Axillae 50 p p TP 
Stomach Para-aortic 51 n n TN 
Stomach Para-aortic 42 n n TN 
Breast Axillae 53 n n TN 
Breast Axillae 54 p p TP 
Breast Axillae 55 p p TP 
Breast Axillae 46 p p TP 
Lymphoma Axillae 57 n p FN 
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Primary Site Lesion Specimen Node No. IC HPE 
Result 
Category. 
Lymphoma Cervical 58 n p FN 
Tongue Cervical 59 p p TP 
Tongue Cervical 60 p p TP 
Thyroid Thyroid 61 n n TN 
Thyroid Thyroid 62 n n TN 
Lymphoma Inguinal 63 n n TN 
Lymphoma Inguinal 64 n n TN 
Testis Pelvic 65 n n TN 
Skin Inguinal 66 n n TN 
Thyroid Thyroid 67 n n TN 
Cervix Para aortic 68 n n TN 
Cervix Para aortic 69 n n TN 
Stomach Para aortic 70 p p TP 
 
TN - True Negative   TP - True Positive 
FN - False Negative   FP - False Positive 
n - Negative                p - Positive 
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NAME LIST - TRUE POSITIVE NODES 
Patient No. Name Node No. IC HPE 
3 Mallika 5 p p 
3 Mallika 6 p p 
4 Kannan 7 p p 
5 Chinnian 8 p p 
7 Raghu 11 p p 
7 Raghu 12 p p 
9 Alagammai 15 p p 
9 Alagammai 16 p p 
10 Hemavathy 17 p p 
14 Noorjehan 23 p p 
16 Dhanalakshmi 27 p p 
17 Antony 28 p p 
20 Elumalai 35 p p 
21 Neelamma 36 p p 
22 Vimala 37 p p 
24 Sammer 39 p p 
24 Sammer 40 p p 
25 Kamakshi 41 p p 
26 Pappammal 42 p p 
31 Lourdhamary 48 p p 
31 Lourdhamary 49 p p 
31 Lourdhamary 50 p p 
34 Indramma 54 p p 
34 Indramma 55 p p 
34 Indramma 56 p p 
37 Kannan 59 p p 
37 Kannan 60 p p 
45 Akbar ali 70 p p 
 
 65
NAME LIST - TRUE NEGATIVE NODES 
Patient No. Name Node No IC HPE 
1 Jeyanthi 1 n n 
1 Jeyanthi 2 n n 
2 Petchiammal 3 n n 
2 Petchiammal 4 n n 
6 Sounderarajan 10 n n 
8 Balaganga 14 n n 
11 Meenakshiammal 18 n n 
12 Chandrashekar 20 n n 
13 Vijaya 22 n n 
15 Chandrashekaran 25 n n 
17 Antony 30 n n 
19 Kanniammal 33 n n 
19 Kanniammal 34 n n 
23 Badhrunnisa 38 n n 
25 Poongothai 45 n n 
29 Kangeyan 46 n n 
32 Raman 51 n n 
32 Raman 52 n n 
33 Selvammal 53 n n 
38 Dhanalakshmi 61 n n 
38 Dhanalakshmi 62 n n 
39 Selvaraj 63 n n 
39 Selvaraj 64 n n 
40 Manikkan 65 n n 
41 Ayyammal 66 n n 
42 Viji 67 n n 
43 Tarabai 68 n n 
44 Ravanammal 69 n n 
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NAME LIST - FALSE NEGATIVE NODES 
Patient No. Name Node No. IC HPE 
8 Balaganga 13 n p 
12 Chandrashekar 19 n p 
12 Chandrashekar 21 n p 
15 Chadnrashekar 24 n p 
17 Antony 29 n p 
18 Antony 31 n p 
18 Antony 32 n p 
26 Pappammal 42 n p 
26 Pappammal 43 n p 
27 Chandra 44 n p 
30 Ram 47 n p 
35 Raman 57 n p 
36 Ganesan 58 n p 
 
NAME LIST - FALSE POSITIVE NODES 
Patient No. Name Node No. IC HPE 
6 Sounderarajan 9 p n 
 
n - Negative   p - Positive 
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DISCUSSION 
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DISCUSSION 
 In this prospective study, we compared the diagnostic accuracy of Touch 
Imprint Cytology in 45 patients on 70 slides, which were suspected to harbor 
pathology for the assessment of histological status. All the patients had a 
 definitive histological diagnosis before inclusion into this study. 
 
 NO. OF NODE/SPECIMEN SLIDE BASED 
Region Count Percent 
 Axillae 14 20 
Cervical  9 13 
 Inguinal 17 24 
 Para-aortic  20 29 
 Pelvic  2 3 
Thyroid  8 11 
 70 100 
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 In total, of the sample assessed from different regions of 45 patients by 
comparing Intra Operative Touch Imprint cytodiagnosis work up followed by 
definitive paraffin sections, we were able to categorize these nodes as follows. 
 I.  No of True positive: 29 
            II.   No   of True negative: 27 
 
             III.   No   of False negative: 13 
 
 IV.    No of False positive: 01 
 
 The sensitivity, specificity, accuracy, positive and negative predictive 
value of Imprint Cytology were calculated relative to final pathologic status as 
follows. 
 Sensitivity FNTP
TP
+  
   %05.69
42
29
1329
29 ==+  
 
 Specificity FNTN
TN
+  
 %43.96
28
27
127
27 ==+  
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PPV  
FPTP
TP
+  
 %67.96
30
29
129
29 ==+  
 
NPV  FNTN
TN
+  
%50.67
40
27
1327
27 ==+  
 
Accuracy 
TNFNFPTP
TNTP
+++
+
 
 %80
70
56
2713129
27 ==+++  
 (NPV – Negative predictive value) 
(PPV – Positive predictive value) 
Results were :  
 A. Sensitivity    - 69.05% 
 B. Specificity    - 96.43% 
 C. Positive predictive value (PPV) - 96.67% 
 D. Negative predictive value (NPV) - 67.50% 
 E. Accuracy    - 80.00% 
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 The sensitivity and specificity are important factors in deciding whether 
a technique should be used. The sensitivity of Touch Imprint cytology in our 
study is 69.05% which is moderately sensitive in comparison to the published 
series ranging from 38 to 96%. 
 The wide disparity between the results of these published studies cannot 
be explained by the methodology alone, but rather due to observer variations. 
Since our protocol requirement is prefixed as one imprint from each half of 
bisected lymph node and also the lymph nodes taken up for the study were 
from a heterogeneous population of sites with a different possible histology of 
the primary cancer, this could have contributed to a moderately lower degree of 
sensitivity. 
 When the data were examined on a per lymph node basis, of the 70 
nodes studied, 42 (60%) nodes harbored metastatic carcinoma on permanent 
section evaluation. If paraffin sections were negative, serial sections were done 
to rule out the presence of occult metastases in the deeper sections. Of these, 29 
were detected on Imprint cytology, resulting in a sensitivity of 69.05%. The 
negative predictive value was 67.50% 
 To minimize the possibility of false positive results at our institution, 
intraoperative indeterminate (atypical / suspicious) results, are regarded as 
negative at the time of surgery and at final diagnosis, unless confirmed positive 
on paraffin section. In our four indeterminate results, 2 turned out to be positive 
and two were negative on final paraffin section. The two cases which were 
negative on the final paraffin section illustrate that reactive histiocytes, 
lymphocytes, and endothelial cells may appear atypical and may be difficult to 
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distinguish from a micro metastasis. Retrospective review of some published 
series confirms that indeterminate results seemed more common with imprint 
cytology than with frozen section, suggesting that this may be a greater 
problem with imprint cytology. 
             SENSITIVITY OF IMPRINT CYTOLOGY IN LITERATURE 
First Author Year No. Of Patients Sensitivity % 
Ku 1999 76 22 
Rubio 1998 53 96 
Van Diest 1999 54 64 
Motomura 2000 101 91 
Ratanawishitrasi 1999 55 93 
Llatjos 2002 76 68 
Henry – Tillman 2002 247 94 
Cserni 2001 60 59 
Baitchev 2002 87 83 
Creager  2002 646 98 
Shiver 2002 127 100 
Lee 2002 65 98 
Barranger 2003 180 98 
Present Study 2005 44 69.05 
   
         In our study, a node from the Para aortic region in a patient with 
carcinoma of bladder contributed to a false positive result. The interpretation of 
isolated tumor cell in that node was due to the presence of an atypical reactive 
lymphocyte, which is also discussed quite extensively in few studies. Hence 
 73
this one false positive case contributed to a mild decrease in our specificity and 
positive predictive value compared to that published series.  
 The accuracy in present study is 80%, which is in the reference range of 
the most widely acclaimed studies published earlier (75 – 99%). 
Possible pitfalls in this study  
 
1. The sample size is small to statistically signify the higher false negative 
rate . Further the sample of nodes taken up for the study is not equally 
distributed among the various regions analyzed. 
2. Since the nodes taken up for the study is heterogeneous in distribution, 
extrapolating the rich axillary nodal experience to other sites should be 
made with caution. 
3. Direct comparison of frozen section could have further bolstered our 
finding in this study. 
4. The use of immunohistochemical staining with CK – IHC could have 
enhanced the sensitivity and deflated the false negative rate in this study.  
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CONCLUSION 
 The results of the current study demonstrate that the accuracy of Imprint 
cytology is high enough to warrant its use for Intraoperative pathological 
assessment. It can be accomplished during primary surgery and does not appear 
to prolong the surgical procedure significantly. The efficacy of the method is 
good. The main limitation of such an approach is an obviously low sensitivity 
for the detection of micro metastases. 
 From the above discussion, it is clear that many gaps remain in our 
knowledge of optimal pathologic analysis of nodal metastases, but some 
tentative general conclusions can be drawn – which may be invalidated by 
subsequent, more definitive studies.  
 Intraoperative pathologic assessment of nodal status should be a joint 
decision between the surgeon and the pathologist, based on the likelihood of 
metastases and the relative risks and benefits to the patient in a given case. 
 Intraoperative cytological Touch imprint on bisected nodes is a 
reasonable approach to identify at least a proportion of the larger metastases, 
without wasting significant lymph node tissue. It should be understood that 
micro metastases are unlikely to be detected by this method, however.  
 Imprint cytology is a viable alternative to traditional frozen section 
when intraoperative evaluation is required. Given its 96.67% specificity 
surgeon may feel confident in basing their Intraoperative decision on touch 
imprint cytology results. Clearly, Imprint cytology evaluation of lymph nodal 
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status lacks sufficient sensitivity to serve as the final diagnostic test. Further 
evaluation of permanent sections using traditional techniques such as H & E 
still remains the gold standard and is indicated. 
 Despite the simplicity, speed and excellent cellular detail the technique 
has still not been fully utilized. We advocate the consideration of Touch 
imprint cytodiagnosis for the evaluation of cases with nodal metastases as a 
valuable alternative to frozen section histology.  
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PROFORMA - IMPRINT CYTOLOGY 
 
 
Name    :                  Age / Sex 
 
Occupation    :  
 
Address    : 
 
M.R.D NO.   :                  C. D. No. 
 
 
 
 
 
Diagnosis    : 
 
                                    Site of Primary: 
 
Stage-CTNM  : 
 
Imprint cytology   :  
                                              Site of node 
      No of nodes 
      Report  
 
Surgery according  
to imprint cytology  : 
 
 
Corresponding HPE : 
Stage - PTNM  : 
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Further treatment  : 
Follow up    : 
 
CASE DETAILS 
Complaints    : 
Present History   : 
Past History   : 
General Examination  : 
Local examination   : 
Systemic examination  : 
Investigations   : 
 X-ray   : 
 Ultrasound   : 
 CT scan  : 
Other Investigations  : 
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